🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Followers are encouraged to message these accounts directly for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with numerous of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Sellers market the substance there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Professionals Voice Worries

However, physicians and pharmacists have cautions that the distribution of what remains an unlicensed medication in the UK is worrisome and could lead to users administering products of uncertain source.

Some professionals stated the demand for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate medicines, advertising, and customer laws, potentially leading to penalties, legal action or imprisonment.

Platform Response and Material Removal

Based on TikTok, the platform has removed violative material and prohibited associated hashtags and search suggestions. The organization said it was committed to maintaining the platform safe and allocating resources in strengthening compliance measures.

Online Marketplace Operations

Research also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with numerous of members, populated with photos of weight loss, glowing testimonials and step-by-step instructions for mixing or injecting at home.

After moments of entering one group, a vendor posted contact information, where the majority of purchases occur. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about weight, health issues or past usage.

Item Details and Pricing

Inside these groups, messages show dark colored packages with Royal Mail labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or pre-filled pens usually priced at £160 for 20mg. When asked how much time a pen should be used, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Security Actions

A representative for the messaging service said it regularly monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting materials they can’t verify. Although the science behind retatrutide is valid, these online products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service linked the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her staff has already encountered patients injured by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company experimental substance not yet authorized … may subject users to potentially significant health risks”.